Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fairhurst

Showing results (141-150 of 179) with videos related to

Pageof 18
Sort By:
The Lancet. Infectious Diseases|September 4, 2012
Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate studyChanaki Amaratunga, Sokunthea Sreng, Seila Suon, et al.
The Journal of Infectious Diseases|December 17, 2013
PlasmoView: a web-based resource to visualise global Plasmodium falciparum genomic variationMark D Preston, Samuel A Assefa, Harold Ocholla, et al.
Antimicrobial Agents and Chemotherapy|August 14, 2013
Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in western, northern, and eastern Cambodia, 2011-2012: association with molecular markersPharath Lim, Dalin Dek, Vorleak Try, et al.
The Lancet. Haematology|December 22, 2015
Effect of red blood cell variants on childhood malaria in Mali: a prospective cohort studyTatiana M Lopera-Mesa, Saibou Doumbia, Drissa Konaté, et al.
Malaria Journal|November 15, 2013
Optimal sampling designs for estimation of Plasmodium falciparum clearance rates in patients treated with artemisinin derivativesJennifer A Flegg, Philippe J Guérin, Francois Nosten, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2024
Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: Primary Results From TROPION-Breast01Aditya Bardia, Komal Jhaveri, Seock-Ah Im, et al.
Antimicrobial Agents and Chemotherapy|April 25, 2013
High-throughput analysis of antimalarial susceptibility data by the WorldWide Antimalarial Resistance Network (WWARN) in vitro analysis and reporting toolCharles J Woodrow, Sabina Dahlström, Richard Cooksey, et al.
Elife|September 27, 2017
Identification of highly-protective combinations of <i>Plasmodium vivax</i> recombinant proteins for vaccine developmentCamila Tenorio França, Michael T White, Wen-Qiang He, et al.
The Journal of Infectious Diseases|May 11, 2019
Contribution of Functional Antimalarial Immunity to Measures of Parasite Clearance in Therapeutic Efficacy Studies of Artemisinin DerivativesKatherine O'Flaherty, Ricardo Ataíde, Sophie G Zaloumis, et al.
The Journal of Infectious Diseases|June 21, 2014
Whole-genome scans provide evidence of adaptive evolution in Malawian Plasmodium falciparum isolatesHarold Ocholla, Mark D Preston, Mwapatsa Mipando, et al.
Pageof 18

Showing results (141-150 of 179) with videos related to

Sort By:
Pageof 18
The Lancet. Infectious Diseases|September 4, 2012
Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate studyChanaki Amaratunga, Sokunthea Sreng, Seila Suon, et al.
The Journal of Infectious Diseases|December 17, 2013
PlasmoView: a web-based resource to visualise global Plasmodium falciparum genomic variationMark D Preston, Samuel A Assefa, Harold Ocholla, et al.
Antimicrobial Agents and Chemotherapy|August 14, 2013
Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in western, northern, and eastern Cambodia, 2011-2012: association with molecular markersPharath Lim, Dalin Dek, Vorleak Try, et al.
The Lancet. Haematology|December 22, 2015
Effect of red blood cell variants on childhood malaria in Mali: a prospective cohort studyTatiana M Lopera-Mesa, Saibou Doumbia, Drissa Konaté, et al.
Malaria Journal|November 15, 2013
Optimal sampling designs for estimation of Plasmodium falciparum clearance rates in patients treated with artemisinin derivativesJennifer A Flegg, Philippe J Guérin, Francois Nosten, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2024
Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: Primary Results From TROPION-Breast01Aditya Bardia, Komal Jhaveri, Seock-Ah Im, et al.
Antimicrobial Agents and Chemotherapy|April 25, 2013
High-throughput analysis of antimalarial susceptibility data by the WorldWide Antimalarial Resistance Network (WWARN) in vitro analysis and reporting toolCharles J Woodrow, Sabina Dahlström, Richard Cooksey, et al.
Elife|September 27, 2017
Identification of highly-protective combinations of <i>Plasmodium vivax</i> recombinant proteins for vaccine developmentCamila Tenorio França, Michael T White, Wen-Qiang He, et al.
The Journal of Infectious Diseases|May 11, 2019
Contribution of Functional Antimalarial Immunity to Measures of Parasite Clearance in Therapeutic Efficacy Studies of Artemisinin DerivativesKatherine O'Flaherty, Ricardo Ataíde, Sophie G Zaloumis, et al.
The Journal of Infectious Diseases|June 21, 2014
Whole-genome scans provide evidence of adaptive evolution in Malawian Plasmodium falciparum isolatesHarold Ocholla, Mark D Preston, Mwapatsa Mipando, et al.
Pageof 18